• Home
  • Talks
  • Sponsors
  • Our Team
  • Diversity, Equity, and Inclusion
  • Subscribe
  • Home
  • Talks
  • Sponsors
  • Our Team
  • Diversity, Equity, and Inclusion
  • Subscribe

Exploring the Virtual Reality Therapeutics (VRx) Pathway


 Duration: 1 hr

Watch Now View Slides
Share the Talk

Talk Overview

AppliedVR develops Virtual Reality Theraputics prescription (VRx). Notably, the company’s EaseVRx product—an investigational device—is the first VR-based prescription therapeutic to receive “Breakthrough Device Designation” from the FDA. Josh Sackman’s talk covers the importance of clinical trials and FDA authorization for VR products, and essential topics about AppliedVR’s transition from a wellness product to a medical device: policies, plans, and procedures involved in conducting a clinical trial, partnering with respected healthcare institutions to navigate the code recommendations of medical societies and CMS, the importance of a rigorous evidence-based path to FDA approvals and clearances in the pursuit of innovative VR therapeutics.

Speakers

Josh Sackman, MBA
President, AppliedVR
LinkedIn

Moderators

Julie LeMoine
Chief Innovation Officer at HorizonIRs, Irish Research Council Scholar, Visiting Scholar at UMass Med School, PhD Candidate University College Dublin
LinkedIn

Organization(s)

Lehigh Valley Health Network

Interested in Donating?

Tax-deductible contributions help pay operating expenses, curriculum development, and fielding the faculty.

Donate Now
MedVR is produced in partnership with Grassroots Developer Education, Inc., a 501(c)(3) non-profit, and the College of Arts, Media, and Design at Northeastern University.
Follow Us
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
Contact Us
  • Get Involved
  • Be a Sponsor